Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.71 USD
Change Today -0.06 / -1.26%
Volume 1.6M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - orexigen therapeutics inc (OREX)

Name (Connections)Board RelationshipsTitleKey Developments
Lota Zoth CPA 40 RelationshipsDirector and Chairperson of Audit Committee 
Louis Bock 46 RelationshipsDirector, Member of Audit Committee and Member of Nominating/Corporate Governance Committee 

Compensation Committee* - orexigen therapeutics inc (OREX)

Name (Connections)Board RelationshipsTitle
Brian Dovey 75 RelationshipsDirector and Chairman of Compensation Committee
Patrick Mahaffy MA 24 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
OREX Compensation vs. Industry
640.6K
363.9K
Chief Executive Officer
379.3K
266.3K
Chief Financial Officer
Share price activity for OREXIGEN THERAPEUTICS INC (OREX)
52 Week Price Performance
OREX
Industry Average

Nominating Committee* - orexigen therapeutics inc (OREX)

Name (Connections)Board RelationshipsTitleKey Developments
Patrick Mahaffy MA 24 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee and Member of Compensation CommitteeOrexigen Therapeutics, Inc. Announces Executive Changes
06/5/15
Louis Bock 46 RelationshipsDirector, Member of Audit Committee and Member of Nominating/Corporate Governance CommitteeOrexigen Therapeutics, Inc. Announces Executive Changes
03/30/15
David Endicott 9 RelationshipsDirector and Member of Nominating/Corporate Governance CommitteeOrexigen Therapeutics, Inc. Appoints David Endicott to its Board
11/30/12

Corporate Governance Committee* - orexigen therapeutics inc (OREX)

Name (Connections)Board RelationshipsTitle
Louis Bock 46 RelationshipsDirector and Chairman of Compensation Committee
David Endicott 9 RelationshipsDirector, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
Patrick Mahaffy MA 24 Relationships--
OREX and Competitor
Insiders vs. External
Board
10%
90%
Orexigen Therapeutics, Inc.
22%
78%
Arena Pharmaceuticals, Inc.
9%
91%
VIVUS Inc.
23%
77%
GlaxoSmithKline plc
12%
88%
Novo Nordisk A/S
Insiders
External Board Members

Advisory Committee* - orexigen therapeutics inc (OREX)

Name (Board Relationships)/Title Board Affiliations
Joseph Lacob 59 Relationships
Member of Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $4.71 USD -0.06

OREX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.48 USD -0.04
GlaxoSmithKline PLC 1,347 GBp +8.50
Novo Nordisk A/S kr363.50 DKK -2.60
VIVUS Inc $2.29 USD -0.02
View Industry Companies
 

Industry Analysis

OREX

Industry Average

Valuation OREX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.0x
Price/Book 48.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.